Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Zand

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Kidney360|March 4, 2026
Should Immunosuppressive Drugs be Stopped after Patients with Proliferative Lupus Nephritis Achieve a Clinical Remission?: CONLadan Zand
Endocrinology and Metabolism Clinics of North America|October 30, 2017
The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney DiseaseLadan Zand, Rajiv Kumar
Kidney International|April 20, 2025
The authors replyLadan Zand, Sanjeev Sethi
Seminars in Dialysis|December 18, 2015
Serum Parathyroid Hormone Concentrations and Clinical Outcomes in ESRD: A Call for Targeted Clinical TrialsLadan Zand, Rajiv Kumar
Kidney International|January 7, 2022
Catastrophic kidney infarctionNattawat Klomjit, Ladan Zand
Transplantation|January 20, 2025
Recurrent FSGS Post-Kidney Transplantations: Where Do We Stand?Mohammed Mahgoub, Ladan Zand
Journal of the American Society of Nephrology : JASN|January 8, 2025
Genotype-Phenotype Correlations with TRPC6-Associated PodocytopathyJing Miao, Ladan Zand
Kidney International|November 21, 2025
The authors replyNattawat Klomjit, Ladan Zand
Kidney International|March 24, 2020
Acquired thoracic kidneyNattawat Klomjit, Ladan Zand
Kidney360|April 4, 2022
Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: COMMENTARYNattawat Klomjit, Ladan Zand
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Kidney360|March 4, 2026
Should Immunosuppressive Drugs be Stopped after Patients with Proliferative Lupus Nephritis Achieve a Clinical Remission?: CONLadan Zand
Endocrinology and Metabolism Clinics of North America|October 30, 2017
The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney DiseaseLadan Zand, Rajiv Kumar
Kidney International|April 20, 2025
The authors replyLadan Zand, Sanjeev Sethi
Seminars in Dialysis|December 18, 2015
Serum Parathyroid Hormone Concentrations and Clinical Outcomes in ESRD: A Call for Targeted Clinical TrialsLadan Zand, Rajiv Kumar
Kidney International|January 7, 2022
Catastrophic kidney infarctionNattawat Klomjit, Ladan Zand
Transplantation|January 20, 2025
Recurrent FSGS Post-Kidney Transplantations: Where Do We Stand?Mohammed Mahgoub, Ladan Zand
Journal of the American Society of Nephrology : JASN|January 8, 2025
Genotype-Phenotype Correlations with TRPC6-Associated PodocytopathyJing Miao, Ladan Zand
Kidney International|November 21, 2025
The authors replyNattawat Klomjit, Ladan Zand
Kidney International|March 24, 2020
Acquired thoracic kidneyNattawat Klomjit, Ladan Zand
Kidney360|April 4, 2022
Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: COMMENTARYNattawat Klomjit, Ladan Zand
Pageof 12